Stock 688513 CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chengdu Easton Biopharmaceuticals Co., Ltd.

Equities

688513

CNE100004397

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
58.38 CNY +0.12% Intraday chart for Chengdu Easton Biopharmaceuticals Co., Ltd. -5.32% -8.47%
Apr. 22 Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 Easton Biopharma's Unit Gets Nod to Market Bisoprolol Amlodipine Tablets MT

Business Summary

Chengdu Easton Biopharmaceuticals Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The Company's main products are chemical generic drugs. Its products include nalmefene hydrochloride injection, caffeine citrate injection, ibuprofen injection, bisoprolol fumarate tablets, ubenimex, etc. Its products are used in the fields of anesthesia and analgesia, cardiovascular, anti-tumor, digestion and children's medicine. The Company operates its businesses within the China market and to overseas markets such as Russia, Switzerland, Tunisia, Germany, South Korea and Japan.

Number of employees: 1,400

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical Preparations
78.8 %
1,019 87.1 % 881 78.8 % -13.61%
Technical Services and Transfer
9.8 %
44 3.8 % 110 9.8 % +150.21%
Application Programming Interface
8.4 %
82 7.0 % 94 8.4 % +14.64%
Contract Manufacturing Organization/Contract Development and Manufacturing Organization
2.8 %
24 2.1 % 31 2.8 % +26.79%
Other
0.1 %
1 0.1 % 1 0.1 % +124.89%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.8 %
1,160 99.1 % 1,103 98.8 % -4.89%
Overseas
1.2 %
10 0.9 % 14 1.2 % +31.87%

Managers

Managers TitleAgeSince
Ming Xu Yuan CEO
 Chief Executive Officer 53 08-12-31
Ying Wang FOU
 Founder 58 09-05-31
Jia Yu Zhu CHM
 Chairman 44 08-12-31
Chen Hong CTO
 Chief Tech/Sci/R&D Officer 60 19-06-30
Zeng Gui Chen BRD
 Director/Board Member 53 08-12-31
Peng Fei Deng BRD
 Director/Board Member 38 11-12-31
Da Ming Zhang BRD
 Director/Board Member 52 08-12-31
Shu Yun Li IRC
 Investor Relations Contact 39 15-09-30

Members of the board

Members of the board TitleAgeSince
Hong Wu Geng BRD
 Director/Board Member 56 21-12-22
Ying Wang FOU
 Founder 58 09-05-31
Da Ming Zhang BRD
 Director/Board Member 52 08-12-31
Ming Xu Yuan CEO
 Chief Executive Officer 53 08-12-31
Jin Li BRD
 Director/Board Member 59 18-12-26
Jia Yu Zhu CHM
 Chairman 44 08-12-31
Peng Fei Deng BRD
 Director/Board Member 38 11-12-31
Fang Fang BRD
 Director/Board Member 42 20-10-12
Zeng Gui Chen BRD
 Director/Board Member 53 08-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 120,090,000 54,530,000 ( 45.41 %) 1,091,092 ( 0.9086 %) 45.41 %

Shareholders

NameEquities%Valuation
Ying Wang
61.59 %
52,300,000 61.59 % 438 M ¥
Guotai Asset Management Co., Ltd.
8.833 %
7,500,391 8.833 % 63 M ¥
Ming Xu Yuan
2.355 %
2,000,000 2.355 % 17 M ¥
Rong Hua Wang
2.355 %
2,000,000 2.355 % 17 M ¥
Da Ming Zhang
1.766 %
1,500,000 1.766 % 13 M ¥
Zeng Gui Chen
1.766 %
1,500,000 1.766 % 13 M ¥
Chang Xin Asset Management Co., Ltd.
1.161 %
985,899 1.161 % 8 M ¥
Great Wall Fund Management Co., Ltd.
0.7031 %
597,040 0.7031 % 5 M ¥
CIB Fund Management Co., Ltd.
0.6682 %
567,411 0.6682 % 5 M ¥
Essence Fund Co., Ltd.
0.4526 %
384,351 0.4526 % 3 M ¥

Company contact information

Chengdu Easton Biopharmaceuticals Co., Ltd.

8 Ankang Road Shuangliu District

610219, Chengdu

+

http://www.eastonpharma.cn
address Chengdu Easton Biopharmaceuticals Co., Ltd.(688513)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Chengdu Easton Biopharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
58.38
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. Stock Chengdu Easton Biopharmaceuticals Co., Ltd.
-8.47% 962M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 334B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 203B
AMGEN INC. Stock Amgen Inc.
+10.77% 171B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 163B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688513 Stock
  4. Company Chengdu Easton Biopharmaceuticals Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW